drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy






































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Week of   





































































































































































































































































Week of Mon, Jul 2nd, 2012

Lilly lands pediatric exclusivity for Cymbalta

Eli Lilly and Co. has obtained pediatric exclusivity for its antidepressant medication Cymbalta.

Lay's adds lower-fat Kettle Cooked chip varieties

Frito-Lay North America has introduced two new potato chip flavors: Lay's Kettle Cooked Applewood Smoked BBQ and Lay's Kettle Cooked Sun-Dried Tomato and Parmesan

OraSure cleared by FDA to market at-home HIV test

OraSure Technologies Inc. has received approval from the Food and Drug Administration for its OraQuick In-Home HIV Test, which the company called the nation's first and rapid, over-the-counter HIV test.

Mylan releases generics of Clarinex, Lithobid

Mylan Inc. has starting shipping desloratadine tablets (5 mg), an allergy medication, and carbonate extended-release tablets (300 mg), a treatment for manic episodes of bipolar disorder.

Cold-EEZE rolls out daytime/nighttime remedy

ProPhase Labs Inc. has launched Cold-EEZE Cold Remedy Daytime/Nighttime QuickMelt tablets.

Bristol-Myers Squibb to buy Amylin for $5.3 billion

Bristol-Myers Squibb Co. plans to acquire Amylin Pharmaceuticals Inc. for $31 per share in cash, pursuant to a cash tender offer and second-step merger, for an aggregate purchase price of about $5.3 billion.

Advertisement